These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37275320)
1. Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting. Komura M; Sato T; Suzuki Y; Yoshikawa H; Nitta NA; Hayashi M; Kuwasaki E; Horikoshi K; Nishioki T; Mori M; Kodama Y; Sasaki S; Takahashi K Can Respir J; 2023; 2023():3302405. PubMed ID: 37275320 [TBL] [Abstract][Full Text] [Related]
2. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881 [TBL] [Abstract][Full Text] [Related]
4. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314 [TBL] [Abstract][Full Text] [Related]
5. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials. Singh D; Wedzicha JA; Siddiqui S; de la Hoz A; Xue W; Magnussen H; Miravitlles M; Chalmers JD; Calverley PMA Respir Res; 2020 Sep; 21(1):240. PubMed ID: 32943047 [TBL] [Abstract][Full Text] [Related]
6. Anti-IL-5 therapies for chronic obstructive pulmonary disease. Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032 [TBL] [Abstract][Full Text] [Related]
7. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469 [TBL] [Abstract][Full Text] [Related]
8. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality. Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000 [TBL] [Abstract][Full Text] [Related]
9. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions. Couillard S; Larivée P; Courteau J; Vanasse A Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201 [TBL] [Abstract][Full Text] [Related]
10. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD. Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740 [TBL] [Abstract][Full Text] [Related]
11. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis. Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722 [TBL] [Abstract][Full Text] [Related]
12. Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis. Chan MC; Yeung YC; Yu ELM; Yu WC Int J Chron Obstruct Pulmon Dis; 2020; 15():2869-2877. PubMed ID: 33204083 [TBL] [Abstract][Full Text] [Related]
13. Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation. Chen TT; Lee KY; Chang JH; Chung CL; Tran HM; Manullang A; Ho SC; Chen KY; Tseng CH; Wu SM; Chuang HC Ann Med; 2023; 55(2):2285924. PubMed ID: 38065676 [TBL] [Abstract][Full Text] [Related]
14. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716 [TBL] [Abstract][Full Text] [Related]
15. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization. Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252 [TBL] [Abstract][Full Text] [Related]
16. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease. Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427 [TBL] [Abstract][Full Text] [Related]
17. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Harries TH; Rowland V; Corrigan CJ; Marshall IJ; McDonnell L; Prasad V; Schofield P; Armstrong D; White P Respir Res; 2020 Jan; 21(1):3. PubMed ID: 31900184 [TBL] [Abstract][Full Text] [Related]
18. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD. Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799 [TBL] [Abstract][Full Text] [Related]
19. Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease. Kwok WC; Chau CH; Tam TCC; Lam FM; Ho JCM Int J Chron Obstruct Pulmon Dis; 2023; 18():1145-1153. PubMed ID: 37332837 [TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD. Antus B; Paska C; Barta I Int J Chron Obstruct Pulmon Dis; 2020; 15():2025-2035. PubMed ID: 32921998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]